Send feedback

MYO7A p.Arg866His

c.2597G>A · rs199607235 · VCV666885

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 6 submitters
AlphaMissense
likely benign
0.1918 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.0033%, sas)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
4
autosomal recessive nonsyndromic hearing loss 2

Computational evidence

Protein change
AlphaMissense0.1918likely benign
REVEL0.521indeterminate
SaProtLLR -9.59tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI<0.2all four deltas below 0.2 · G>T here scores Δ0.23 · evaluated, not missing
Constraint at this position
ConservationphyloP 9.7GERP 1.6, phastCons 1
Regional constrainto/e 0.95unconstrained · MANE · 84 kb · p 0.0065 · regional, not allelic
Overall
CADD23.8PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0033% South Asian · 3/90,844 alleles
Filtering AF 0.000877% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000539%
Overall 0.00149% 24/1,612,248 alleles · very rare exomes 20/1,460,098 · genomes 4/152,150 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0048% 20,812
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,598
South Asiangrpmax 0.0033% 30,281
African / African-American 0.00267% 37,448
Finnishnot grpmax-eligible 0.00159% 62,998
European (non-Finnish) 0.00119% 84,263

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7A
Protein
p.Arg866His
Coding
c.2597G>A
MANE Select
NM_000260
dbSNP
rs199607235
Type
single nucleotide variant
Location
chr11:77180384 (GRCh38)
Gene constraint
LOEUF 0.995 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 77.73 · 1 PDB
Residue 866
the 'sah' region
Full MYO7A gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7a-p-arg866his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown